Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
European journal of haematology
View this publicationEuropean journal of haematology
View this publicationOrphanet journal of rare diseases
View this publicationPublication categories: Top publication
Nature communications
View this publicationBMC cardiovascular disorders
View this publicationAllergy
View this publicationCell research
View this publicationBone research
View this publicationScientific reports
View this publicationDevelopmental cell
View this publicationInnere Medizin (Heidelberg, Germany)
View this publication